Eric Loh has more than 20 years of experience in the medical device industry. Eric played significant roles in developing Biosensors International, an early-stage cardiovascular device company, to a successful, publicly traded company on the Singapore Stock Exchange. In his role as the Managing Director of Biosensors, he oversaw the establishment of a joint venture operation in China and led successful sales and marketing efforts in several markets in Asia Pacific while managing two manufacturing facilities in Singapore. In 2005, Eric was involved with the company’s IPO on the Singapore Stock Exchange. He continued to lead the corporate development and was involved in several M&A transactions that brought value to the company. After leaving Biosensors, Eric was the CEO of another start-up, EPI Mobile Health, and achieved FDA, CE and HSA approvals of the novel mobile ECG device leading to the commercialisation of the products in key markets in Asia.
Day 2, 13 October 2022 , Thursday, 0940 – 0950hrs
Session 5: 13 Oct 2022, Thurs, 0900 - 1030hrs
Track : Track 1C: Harnessing the Power of MedTech Innovations in Healthcare (Level 2, Garnet 218 - 219)
Topic : Public Private Partnerships – *Trendlines Medical Singapore